John Spillane

845 total citations
23 papers, 369 citations indexed

About

John Spillane is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, John Spillane has authored 23 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 9 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in John Spillane's work include Cutaneous Melanoma Detection and Management (14 papers), Melanoma and MAPK Pathways (7 papers) and Nonmelanoma Skin Cancer Studies (4 papers). John Spillane is often cited by papers focused on Cutaneous Melanoma Detection and Management (14 papers), Melanoma and MAPK Pathways (7 papers) and Nonmelanoma Skin Cancer Studies (4 papers). John Spillane collaborates with scholars based in Australia, United States and United Kingdom. John Spillane's co-authors include Michael A. Henderson, David Gyorki, David Speakman, John Slavin, Graham Byrnes, Janine A. Danks, T. John Martin, John L. Hopper, Peter Choong and Angela Webb and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Clinical Pathology.

In The Last Decade

John Spillane

23 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Spillane Australia 11 280 148 54 43 42 23 369
Danielle Shafer United States 12 151 0.5× 169 1.1× 39 0.7× 48 1.1× 45 1.1× 30 398
David Speakman Australia 14 310 1.1× 110 0.7× 62 1.1× 52 1.2× 92 2.2× 30 423
Lukas Marcelis Belgium 12 186 0.7× 102 0.7× 28 0.5× 98 2.3× 34 0.8× 26 487
Jeff Kutok United States 6 108 0.4× 226 1.5× 54 1.0× 60 1.4× 66 1.6× 10 428
Cristiane Milito Brazil 10 133 0.5× 109 0.7× 30 0.6× 46 1.1× 35 0.8× 26 309
Subhayan Chattopadhyay Sweden 11 125 0.4× 71 0.5× 87 1.6× 25 0.6× 49 1.2× 37 321
Maria Rosaria Sapienza Italy 11 228 0.8× 88 0.6× 45 0.8× 109 2.5× 23 0.5× 25 429
Geetha Menezes United States 8 226 0.8× 117 0.8× 89 1.6× 30 0.7× 50 1.2× 12 385
Clay M. Anderson United States 9 134 0.5× 98 0.7× 43 0.8× 48 1.1× 73 1.7× 13 296
Damian J. Ralser Germany 11 110 0.4× 132 0.9× 28 0.5× 51 1.2× 73 1.7× 35 325

Countries citing papers authored by John Spillane

Since Specialization
Citations

This map shows the geographic impact of John Spillane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Spillane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Spillane more than expected).

Fields of papers citing papers by John Spillane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Spillane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Spillane. The network helps show where John Spillane may publish in the future.

Co-authorship network of co-authors of John Spillane

This figure shows the co-authorship network connecting the top 25 collaborators of John Spillane. A scholar is included among the top collaborators of John Spillane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Spillane. John Spillane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, T. S., Barbara Perić, Robyn P.M. Saw, et al.. (2024). Leg Lymphoedema After Inguinal and Ilio-Inguinal Lymphadenectomy for Melanoma: Results from a Prospective, Randomised Trial. Annals of Surgical Oncology. 31(6). 4061–4070. 1 indexed citations
2.
Liu, David S., Tim Bright, Ahmad Aly, et al.. (2023). Understanding Potentially Preventable Mortality Following Oesophago-Gastric Cancer Surgery: Analysis of a National Audit of Surgical Mortality. Annals of Surgical Oncology. 30(8). 4950–4961. 7 indexed citations
3.
Milne, Donna, Lumine Na, John Spillane, et al.. (2019). Negative Sentinel Lymph Node Biopsy in Patients with Melanoma: The Patient’s Perspective. Annals of Surgical Oncology. 26(7). 2263–2267. 6 indexed citations
4.
Hicks, Rodney J., et al.. (2019). The Prognosis and Natural History of In-Transit Melanoma Metastases at a High-Volume Centre. Annals of Surgical Oncology. 26(13). 4673–4680. 5 indexed citations
5.
Spillane, John, et al.. (2018). Melanoma in the very elderly, management in patients 85 years of age and over. Journal of Geriatric Oncology. 9(5). 488–493. 15 indexed citations
6.
Lewin, Jeremy, Damien Kee, Alan Herschtal, et al.. (2017). Surveillance imaging with FDG-PET/CT in the post-operative follow-up of stage 3 melanoma.. Journal of Clinical Oncology. 35(15_suppl). 9563–9563. 1 indexed citations
7.
Boyle, Samantha E., Clare G. Fedele, Vincent Corbin, et al.. (2016). CD271 Expression on Patient Melanoma Cells Is Unstable and Unlinked to Tumorigenicity. Cancer Research. 76(13). 3965–3977. 24 indexed citations
8.
9.
Spillane, John, David Speakman, Christopher McCormack, et al.. (2016). Localized melanoma in older patients, the impact of increasing age and comorbid medical conditions. European Journal of Surgical Oncology. 42(9). 1359–1366. 22 indexed citations
10.
Estall, Vanessa, Angela Allen, Angela Webb, et al.. (2016). Outcomes following management of squamous cell carcinoma of the scalp: A retrospective series of 235 patients treated at the Peter MacCallum Cancer Centre. Australasian Journal of Dermatology. 58(4). e207–e215. 13 indexed citations
11.
Lewin, Jeremy, Damien Kee, Michael A. Henderson, et al.. (2015). Surveillance imaging with FDG-PET in the follow-up of melanoma patients at high risk of relapse.. Journal of Clinical Oncology. 33(15_suppl). 9003–9003. 4 indexed citations
12.
Gyorki, David, Alan Herschtal, Smaro Lazarakis, et al.. (2015). Sentinel Lymph Node Biopsy in T4 Melanoma: An Important Risk-Stratification Tool. Annals of Surgical Oncology. 23(2). 579–584. 20 indexed citations
13.
Ng, Bee Ling, John Spillane, David Speakman, et al.. (2015). Post‐operative survival following metastasectomy for patients receiving BRAF inhibitor therapy is associated with duration of pre‐operative treatment and elective indication. Journal of Surgical Oncology. 111(8). 980–984. 19 indexed citations
14.
Gyorki, David, John Spillane, David Speakman, Mark Shackleton, & Michael A. Henderson. (2014). Current management of advanced melanoma: a transformed landscape. ANZ Journal of Surgery. 84(9). 612–617. 12 indexed citations
15.
Spillane, John & Michael A. Henderson. (2012). Improving care for patients with melanoma. ANZ Journal of Surgery. 82(1-2). 3–5. 1 indexed citations
16.
Gavriel, Haim, Cuong Duong, John Spillane, & Andrew Sizeland. (2012). Bidirectional esophageal dilatation in pharyngoesophageal stenosis postradiotherapy. Head & Neck. 35(5). 733–737. 10 indexed citations
17.
Spillane, John & Michael A. Henderson. (2007). CANCER STEM CELLS: A REVIEW. ANZ Journal of Surgery. 77(6). 464–468. 61 indexed citations
18.
Henderson, Michael A., Janine A. Danks, John Slavin, et al.. (2006). Parathyroid Hormone–Related Protein Localization in Breast Cancers Predict Improved Prognosis. Cancer Research. 66(4). 2250–2256. 92 indexed citations
19.
Spillane, John, et al.. (2002). Clostridium novyi causing necrotising fasciitis in an injecting drug user. Journal of Clinical Pathology. 55(2). 141–142. 5 indexed citations
20.
Spillane, John. (1998). The Making of an Underground Market: Drug Selling in Chicago, 1900-1940. Journal of Social History. 32(1). 27–47. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Danielle Shafer Breakdown of academic impact, for papers by David Speakman Breakdown of academic impact, for papers by Lukas Marcelis Breakdown of academic impact, for papers by Jeff Kutok Breakdown of academic impact, for papers by Cristiane Milito Breakdown of academic impact, for papers by Subhayan Chattopadhyay Breakdown of academic impact, for papers by Maria Rosaria Sapienza Breakdown of academic impact, for papers by Geetha Menezes Breakdown of academic impact, for papers by Clay M. Anderson Breakdown of academic impact, for papers by Damian J. Ralser
Rankless by CCL
2026